|
(b)(6).This report includes information known at this time.A follow-up report will be submitted should additional relevant information become available.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|
|
As reported, during treatment of a calcified lesion within the iliac artery, an advance 35 lp low profile balloon catheter's balloon ruptured upon the first inflation.Access was obtained in the femoral artery, and another manufacturer's 6 french sheath was used.The device was inflated with a syringe and the inflation pressure is unknown.The balloon was removed by itself and another device was used to complete the procedure.There were no adverse effects to the patient.
|
|
Blank fields on this form indicate the information is unknown, unchanged, or unavailable.Corrected information: g3 on the initial report should have been 20jun2022, not 17jun2022.Summary of event: as reported, during treatment of a calcified lesion within the iliac artery, an advance 35 lp low profile balloon catheter's balloon ruptured upon the first inflation.Access was obtained in the femoral artery, and another manufacturer's 6 french sheath was used.The device was inflated with a syringe and the inflation pressure is unknown.The balloon was removed by itself, and another device was used to complete the procedure.There were no adverse effects to the patient.Investigation evaluation: reviews of the complaint history, device history record, drawing, instructions for use (ifu), and quality control procedures were conducted during the investigation.The complaint device was not returned to cook for investigation.A document-based investigation evaluation was performed.No related non-conformances were found, and there have been no other reported complaints for this lot number.The product ifu warns, ¿under fluoroscopy, advance the balloon to the lesion site.Carefully position the balloon across the lesion using both the distal and proximal radiopaque balloon markers.Note: if resistance is met while advancing the balloon dilation catheter, determine the cause and proceed with caution.¿ the information provided upon review of the dmr, dhr, and ifu suggests that there is evidence the device was manufactured to specification.There is no evidence of non-conforming devices in-house or in the field.Cook has concluded that sufficient inspection activities are in place to identify this failure mode prior to distribution.Based on the information provided and the results of the investigation, cook has concluded that the patient¿s calcified anatomy contributed to this event.The risk analysis for this failure mode was reviewed and no additional escalation was required.The appropriate personnel have been notified and cook will continue to monitor for similar events.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|